Response of adult patients with osteomalacia to treatment with crystalline 1alpha-hydroxy vitamin D3.
D000368:Aged; D001706:Biopsy; D001862:Bone Resorption / Q000473:pathology; D001842:Bone and Bones / Q000166:cytology / Q000473:pathology; D002118:Calcium / Q000032:analysis / Q000097:blood; D002452:Cell Count; D003460:Crystallization; D005243:Feces / Q000032:analysis; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000008:administration & dosage / Q000627:therapeutic use*; D006909:Hydroxyproline / Q000652:urine; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010012:Osteogenesis; D010018:Osteomalacia / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D010710:Phosphates / Q000652:urine; D010758:Phosphorus / Q000032:analysis / Q000097:blood
D006887:Hydroxycholecalciferols; D010710:Phosphates; D010758:Phosphorus; D006909:Hydroxyproline; D002118:Calcium